Alzheimer’s Drug Discovery Foundation (ADDF) Announces Launch of SpeechDx, the First Study to…
The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostic Accelerator (DxA) announced the launch of SpeechDx, the first longitudinal study aimed at creating the largest repository…
Read More...
Read More...
